Funding Links #3

Scheme Details Typical timelines and budget
BHF Translational Award Supports the pre-clinical development of new cardiovascular medicines and technologies so that they are attractive for follow-on funding: bridging the funding gap between promising innovations and the clinic £250k
CRUK Small Molecule Drug Discovery Project Awards Identify and characterise small molecule novel therapeutic targets and to identify and develop novel therapeutic entities for the benefit of cancer patients. New target identification & validation. One to three years, £300k
GSK Discovery Partnership with Academia Integrated GSK-academic partnerships that can translate innovative research Six -12 months
Innovate UK Multiple schemes which are updated regularly, ranging from small innovation vouchers to large, collaborative programmes. Usually industry-led. Various
MRC Biomedical catalyst Early stage, small molecule, drug discovery.  Will fund development of therapeutics. Up to three years, £3M
Royal Society Innovation Award For scientists who wish to develop an already proven concept or prototype into a near-market product, ready for commercial exploitation. Up to two years, £250k
Wellcome Trust Seed award Small, one-off grants to help researchers develop original and innovative ideas to a position where they would be able to be competitive for a larger award from the Wellcome Trust, or another source. Up to two years, £100k
Worldwide Cancer Research Funding for basic and translational research into the causes, mechanisms, diagnosis, treatment or prevention of cancer 12-36 months, £250k